K-numberK240924
Device nameAnterion
ApplicantHeidelberg Engineering GmbH
Product codeOBO
Device classClass II
Decision dateDec 13, 2024
DecisionSubstantially Equivalent
Regulation886.1570
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ANTERION is a non-contact ophthalmic imaging device using swept-source OCT technology to visualize and measure the anterior segment of the eye, including corneal thickness (epithelial and stromal), anterior chamber parameters (width, depth, volume, angle), lens thickness, and axial length. The device consists of hardware with integrated forehead/chin rest and software with four apps (Imaging, Cornea, Cataract, Metrics) for different measurement and analysis functions.

Technological characteristics

The subject device is identical to the predicate (K230897) in main technology (swept-source OCT at 1310 nm), supporting technologies (infrared camera), optical specifications (axial/lateral resolution, scan patterns, A-scan rate), and all four software apps. The primary difference is the addition of an Epithelial Thickness Module within the Cornea App, which provides new measurements of corneal epithelial and stromal thickness via separate licensing. Only maintenance-level hardware assembly changes were implemented with no impact on device performance.

Test standards cited

IEC 60601-1:2020 (electrical safety), IEC 60601-1-2:2020 and IEC TR 60601-4-2:2016 (electromagnetic compatibility), IEC 60825-1:2007 and ANSI Z80.36:2016 (laser safety), ISO 10993-5:2009, ISO 10993-10:2021, and ISO 10993-18:2005 (biocompatibility), ISO 10993-1:2018 (biocompatibility assessment), and ISO 14971:2019 (risk assessment).

Substantial equivalence argument

Substantial equivalence is established because the subject device maintains identical intended use and data acquisition modes as the predicate, utilizes the same OCT and infrared imaging technologies, and has equivalent optical and scanning specifications. Although the Epithelial Thickness Module is a new software feature, it does not alter the data acquisition process, imaging technologies, or core indications for use. Clinical study B-2020-1 demonstrates that epithelial thickness measurements from the subject device have precision (repeatability and reproducibility) comparable to or better than the Cirrus HD-OCT 5000 predicate across normal and abnormal cornea populations, with acceptable systematic measurement differences attributable to different scan strategies. Non-clinical testing confirms the device meets applicable electrical safety, EMC, and laser safety standards. No adverse events were reported.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →